MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jconrel.2019.08.015

Медицинская библиотека · Journal of controlled release : official journal of the Controlled Release Society · 2019

Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis.

Codullo Veronica, Cova Emanuela, Pandolfi Laura, Breda Silvia, Morosini Monica, Frangipane Vanessa, Malatesta Manuela, Calderan Laura, Cagnone Maddalena, Pacini Chiara, Cavagna Lorenzo, Recalde Helios, Distler Jörg H W, Giustra Marco, Prosperi Davide, Colombo Miriam, Meloni Federica, Montecucco Carlomaurizio

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Interstitial lung involvement in Systemic Sclerosis (SSc-ILD) is a complication with high morbidity and mortality. Specifically, engineered gold nanoparticles (GNPs) are proposed as targeted delivery system increasing efficacy of drugs with antifibrotic effect, such as tyrosine kinases. We aimed to test in vitro and in vivo the activity of targeted Imatinib (Im)-loaded GNP on SSc-ILD patients derived cells and in experimental model of lung fibrosis. GNPs functionalized with anti-CD44 and loaded with Im (GNP-HCIm) were synthesized. Lung fibroblasts (LFs) and alveolar macrophages from bronchoalveolar lavage fluids of SSc-ILD patients were cultured in presence of nanoparticles. GNP-HCIm significantly inhibited proliferation and viability inducing apoptosis of LFs and effectively reduced IL-8 release, viability and M2 polarization in alveolar macrophages. Anti-fibrotic effect of tracheal instilled GNP-HCIm was evaluated on bleomycin lung fibrosis mouse model comparing effect with common route of Im administration. GNP-HCIm were able to reduce significantly lung fibrotic changes and collagen deposition. Finally, electron microscopy revealed the presence of GNPs inside alveolar macrophages. These data support the use of GNPs locally administered in the development of new therapeutic approaches to SSc-ILD.

Для цитирования: Codullo Veronica, Cova Emanuela, Pandolfi Laura, Breda Silvia, Morosini Monica, Frangipane Vanessa, Malatesta Manuela, Calderan Laura, Cagnone Maddalena, Pacini Chiara, Cavagna Lorenzo, Recalde Helios, Distler Jörg H W, Giustra Marco, Prosperi Davide, Colombo Miriam, Meloni Federica, Montecucco Carlomaurizio. Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis.. Journal of controlled release : official journal of the Controlled Release Society. 2019. DOI: 10.1016/j.jconrel.2019.08.015.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.